New York - chaired by Atanas Goranov, Managing Director, Derivatives Risk Officer, Guardian Life Insurance Company of America , ONLY ONE DAY LEFT TO SECURE THE EARLY BOOKING DISCOUNT - OFFER ENDS FRIDAY 3 FEB

The Cost of Central Clearing - Liquidity Impact for the Buy Side

London
13 March 2012
New York
20 March 2012

***** DO NOT ENTER ANYTHING HERE OR REMOVE THIS BLOCK. THIS IS A HACK TO USE STYLESHEET TO CONTROL THE LAYOUT ****

Learning outcomes:

  • Definitive overview of the regulation governing changes in OTC derivatives trading
  • A clear understanding of what collateral assets are considered eligible
  • Identifying methods of collateral optimisation
  • Create strategies to ensure an effective margining regime
  • Understanding the effect on liquidity of a CCP or member default
  • Reviewing the operational costs involved in portability agreements
  • An understanding of which CCP platform is appropriate for your clearing requirements

 

Course Highlights

  • Understand the current regulatory environment
  • Discuss how central counterparty clearing will impact collateral management
  • Address the operational costs of central clearing for the buy side
  • Understand how to develop an efficient procedure for posting margin
  • Consider the competitive nature of CCP's and the potential effect on the end user
  • Consider factors that may effect your choice of CCP

Course dates & venues

LONDON 13 March 2012

NEW YORK 20 March 2012

VENUE DETAILS

arrowBOOK NOW

 

 

Course Tutors

LONDON

Seminar chaired by  Jacqueline Walsh, Group Derivatives Operational Officer, F&C Asset Management

Matteo Bertotti,
Head of Fixed Income Derivatives , MPS Capital Services
Nick Burge,
Head of Alternative Fund Sales, Lloyds Banking Group
Rory Cunningham,
 Head of European Public Affairs, LCH.Clearnet
Samuel Ely
, former Managing Principal, Capco 
Matthias Graulich,
Executive Director, Head of Clearing Initiatives, Eurex Group
Mark Higgins,
Business Development Director - EMEA, The Bank of New York Mellon
Eric Kolodner, Managing Director, Tradeweb
Andrew Sterry, Director, Citi Prime Finance
Martin Higgs,
Senior Vice President, State Street Bank & Trust Company
Richard Walker,
Executive Director, SwapClear Sales and Marketing, Europe, LCH.Clearnet
Jacqueline Walsh,
Group Derivatives Operational Officer, F&C Asset Management
John Wilson,
Former Managing Director & Global Head of OTC Clearing, RBS

NEW YORK

Seminar chaired by Atanas Goranov, Managing Director, Derivatives Risk Officer, Guardian Life Insurance Company of America

Byron Baldwin, Senior Vice President, Eurex
James Cawley, CEO, Javelin Capital Markets
Samuel Ely,
former Managing Principal, Capco
Ronald Filler, Former Managing Director Lehman Brothers and Director, NY Law School
Atanas Goranov, Managing Director, Derivatives Risk Officer, Guardian Life Insurance Company of America
Steve Mahoney, Managing Director, Credit Suisse
Jeffrey Maron,
Managing Director, MarkitSERV
Andrew McGuire,
Senior Vice President, Sales and Marketing US, LCH.Clearnet
Mariam Rafi,
 North American Head of OTC Clearing, Citi
Jennifer C. Peve, Director, OTC Product Management, CME Group
Kevin Samborn, Vice President, Valuation and Risk Analytics, Sapient Global Markets